Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy

摘要

BackgroundThe efficacy of adjunctive aripiprazole in patients with major depressive disorder (MDD) with no improvement after 8weeks of prior antidepressant monotherapy has not been evaluated.